Pharmacological neuroprotection after perinatal asphyxia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue SUPPL. 3, 2010, Pages 17-19

  Fan, Xiyong ^a,b   Van Bel, Frank ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

asphyxia; Brain; neonate; neuroprotection; pharmacology

Indexed keywords

2 IMINOBIOTIN; 7 NITROINDAZOLE; ALLOPURINOL; AMINOGUANIDINE; DEXAMETHASONE; ERYTHROPOIETIN; FREE RADICAL; I KAPPA B; MELATONIN; NEUROPROTECTIVE AGENT; NEUROTROPHIC FACTOR; NICARDIPINE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TAT COUPLED NF KAPPA B ESSENTIAL MODULATOR BINDING DOMAIN PEPTIDE; UNCLASSIFIED DRUG; XENON;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BRAIN DAMAGE; BRAIN INJURY; BRAIN ISCHEMIA; DRUG EFFICACY; DRUG TARGETING; DRUG WITHDRAWAL; HUMAN; HYPOTENSION; INDUCED HYPOTHERMIA; INFANT; INTERMETHOD COMPARISON; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PERINATAL ASPHYXIA; PRIORITY JOURNAL; REVIEW; CELL PROTECTION; DRUG EFFECT; EVALUATION; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEONATOLOGY; NEWBORN; NEWBORN HYPOXIA; NEWBORN INTENSIVE CARE; PATHOPHYSIOLOGY;

ASPHYXIA NEONATORUM; COMBINED MODALITY THERAPY; CYTOPROTECTION; HUMANS; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; NEONATOLOGY; NEUROPROTECTIVE AGENTS;

EID: 77957959113     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.505052     Document Type: Review

References (24)

1. Cilio MR, Ferriero DM. Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonatal Med 2010; doi:10.1016/j.siny.2010.02.002.
2. Kittaka M, Giannotta SL, Zelman V, Correale JD, DeGiorgio CM,Weiss MH, Zlokovic BV. Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model. J Neurosurg 1997;87:731-737.
3. Hobbs C, Thoresen M, Tucker A, Aquilina K, Chakkarapani E, Dingley J. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke 2008;39:1307-1313.
4. Taskin E, Ozcan K, Canacankatan N, Satar M, Yapicioglu HY, Erdogan S. The effects of indomethacin on caspases, glutathione level and lipid peroxidation in the newborn rats with hypoxic-ischemic cerebral injury. Brain Res 2009; 1289:118-123.
5. Torrance HL, Benders MJ, Derks JB, Rademaker CM, Bos AF, Van Den Berg P, Longini M, Buonocore G, Venegas M, Baquero H, Visser GH, Van Bel F. Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B. Pediatrics 2009;124:350-357.
6. Benders MJ, Bos AF, Rademaker CM, Rijken M, Torrance HL, Groenendaal F, van Bel F. Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia. Arch Dis Child Fetal Neonatal Ed 2006;91:F163-F165.
7. Miller SP, Mayer EE, Clyman RI, Glidden DV, Hamrick SE, Barkovich AJ. Prolonged indomethacin exposure is associated with decreased white matter injury detected with magnetic resonance imaging in premature newborns at 24 to 28 weeks gestation at birth. Pediatrics 2006;117:1626-1631.
8. Van den Tweel ER, Peeters-Scholte CM, van Bel F, Heijnen CJ, Groenendaal F. Inhibition of nNOS and iNOS following hypoxia-ischaemia improves long-term outcome but does not influence the inflammatory response in the neonatal rat brain. Dev Neurosci 2002;24:389-395.
9. Nijboer CH, Groenendaal F, Kavelaars A, Hagberg HH, van Bel F, Heijnen CJ. Gender-specific neuroprotection by 2- iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway. J Cereb Blood Flow Metab 2007;27:282-292.
10. van der Kooij MA, Nijboer CH, Ohl F, Groenendaal F, Heijnen CJ, van Bel F, Kavelaars A. NF-kappa B inhibition after neonatal cerebral hypoxia-ischemia improves long-term motor and cognitive outcome in rats. Neurobiol Dis 2010;38:266-272.
11. Nijboer CH, van der KooijMA, van Bel F, Ohl F, Heijnen CJ, Kavelaars A. Inhibition of the JNK/AP-1 pathway reduces neuronal death and improves behavioral outcome after neonatal hypoxic-ischemic brain injury. Brain Behav Immun 2010;24:812-821.
12. van der Kooij MA, Groenendaal F, Kavelaars A, Heijnen CJ, van Bel F. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia. Brain Res Rev 2008;59:22-33.
13. Zhu C, Kang W, Xu F, Cheng X, Zhang Z, Jia L, Ji L, Guo X, Xiong H, Simbruner G, Blomgren K, Wang X. Erythropoietin improved neurologic outcomes in newborns with hypoxicischemic encephalopathy. Pediatrics 2009;124:e218-e226.
14. Demers EJ, McPherson RJ, Juul SE. Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res 2005;58:297-301.
15. Welin AK, Svedin P, Lapatto R, Sultan B, Hagberg H, Gressens P, Kjellmer I, Mallard C. Melatonin reduces inflammation and cell death in white matter in the midgestation fetal sheep following umbilical cord occlusion. Pediatr Res 2007;61:153-158.
16. Reiter RJ, Calvo JR, Karbownik M, Qi W, Tan DX. Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 2000;917:376-386.
17. Gill R, Soriano M, Blomgren K, Hagberg H, Wybrecht R, Miss MT, Hoefer S, Adam G, Niederhauser O, Kemp JA, Loetscher H. Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain. J Cereb Blood Flow Metab 2002;22:420-430.
18. Alagappan D, Lazzarino DA, Felling RJ, Balan M, Kotenko SV, Levison SW. Brain injury expands the numbers of neural stem cells and progenitors in the SVZ by enhancing their responsiveness to EGF. ASN Neuro 2009;1:e00009.
19. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004;35:1732-1737.
20. Gonzalez FF, McQuillen P, Mu D, Chang Y, Wendland M, Vexler Z, Ferriero DM. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 2007;29:321-330.
21. Lin S, Fan LW, Rhodes PG, Cai Z. Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats. Exp Neurol 2009;217:361-370.
22. Galvin KA, Oorschot DE. Continuous low-dose treatment with brain-derived neurotrophic factor or neurotrophin-3 protects striatal medium spiny neurons from mild neonatal hypoxia/ischemia: a stereological study. Neuroscience 2003; 118:1023-1032.
23. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. Mesenchymal stem cell treatment after neonatal hypoxicischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun 2010;24:387-393.
24. Rivera FJ, Sierralta WD, Minguell JJ, Aigner L. Adult hippocampus derived soluble factors induce a neuronal-like phenotype in mesenchymal stem cells. Neurosci Lett 2006; 406:49-54.